AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,886 | +24.6% | 71,830 | -0.0% | 0.00% | – |
| Q2 2023 | $65,730 | +63.3% | 71,836 | 0.0% | 0.00% | – |
| Q1 2023 | $40,257 | -2.9% | 71,836 | 0.0% | 0.00% | – |
| Q4 2022 | $41,449 | +80.2% | 71,836 | 0.0% | 0.00% | – |
| Q3 2022 | $23,000 | -11.5% | 71,836 | 0.0% | 0.00% | – |
| Q2 2022 | $26,000 | -94.3% | 71,836 | -88.8% | 0.00% | – |
| Q1 2022 | $459,000 | -67.5% | 638,883 | +2.2% | 0.00% | – |
| Q4 2021 | $1,413,000 | -17.1% | 624,845 | +5.6% | 0.00% | – |
| Q3 2021 | $1,704,000 | -20.0% | 591,829 | +5.3% | 0.00% | – |
| Q2 2021 | $2,130,000 | +5.5% | 562,155 | -5.7% | 0.00% | – |
| Q1 2021 | $2,019,000 | +9.5% | 596,229 | -9.4% | 0.00% | – |
| Q4 2020 | $1,843,000 | +27.1% | 657,911 | +13.8% | 0.00% | – |
| Q3 2020 | $1,450,000 | -83.1% | 578,026 | -8.4% | 0.00% | -100.0% |
| Q2 2020 | $8,573,000 | +91.4% | 631,308 | +6.8% | 0.00% | +100.0% |
| Q1 2020 | $4,480,000 | +2.4% | 591,102 | -14.6% | 0.00% | 0.0% |
| Q4 2019 | $4,376,000 | +67.0% | 692,358 | +3.6% | 0.00% | 0.0% |
| Q3 2019 | $2,621,000 | -19.5% | 668,557 | -0.6% | 0.00% | 0.0% |
| Q2 2019 | $3,256,000 | -28.2% | 672,874 | +21.5% | 0.00% | 0.0% |
| Q1 2019 | $4,537,000 | +49.5% | 553,993 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $3,034,000 | +59.9% | 548,595 | +155.1% | 0.00% | – |
| Q3 2018 | $1,898,000 | -11.4% | 215,026 | +0.1% | 0.00% | -100.0% |
| Q2 2018 | $2,143,000 | +12.1% | 214,720 | +7.0% | 0.00% | 0.0% |
| Q1 2018 | $1,911,000 | -48.9% | 200,631 | -20.2% | 0.00% | 0.0% |
| Q4 2017 | $3,737,000 | -15.2% | 251,393 | +12.2% | 0.00% | 0.0% |
| Q3 2017 | $4,406,000 | +53.4% | 223,985 | +12.1% | 0.00% | 0.0% |
| Q2 2017 | $2,872,000 | +112.7% | 199,818 | +36.1% | 0.00% | – |
| Q1 2017 | $1,350,000 | -12.3% | 146,806 | -0.7% | 0.00% | – |
| Q4 2016 | $1,539,000 | +33.4% | 147,782 | +15.9% | 0.00% | – |
| Q3 2016 | $1,154,000 | +18.8% | 127,457 | -1.9% | 0.00% | – |
| Q2 2016 | $971,000 | -10.2% | 129,975 | +8.3% | 0.00% | – |
| Q1 2016 | $1,081,000 | -44.0% | 119,993 | -19.7% | 0.00% | -100.0% |
| Q4 2015 | $1,930,000 | +36.7% | 149,363 | +2.2% | 0.00% | – |
| Q3 2015 | $1,412,000 | +91.8% | 146,150 | +104.3% | 0.00% | – |
| Q2 2015 | $736,000 | +89.7% | 71,554 | +104.9% | 0.00% | – |
| Q1 2015 | $388,000 | -4.4% | 34,914 | -0.1% | 0.00% | – |
| Q4 2014 | $406,000 | -38.9% | 34,939 | +16.2% | 0.00% | – |
| Q3 2014 | $665,000 | -58.2% | 30,078 | -47.4% | 0.00% | – |
| Q2 2014 | $1,590,000 | – | 57,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |